Who is sponsoring NCT05067114?

NCT05067114 is sponsored by American Pharmacists Association Foundation.

What drugs are being tested in NCT05067114?

Interventions in NCT05067114: Screening, detection and referral for atrial fibrillation.

What condition does NCT05067114 study?

NCT05067114 studies Cardiovascular Diseases, Cardiac Arrhythmia, Atrial Fibrillation.

Is NCT05067114 still recruiting?

NCT05067114 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT05067114: SAFE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Solutions for Atrial Fibrillation Edvocacy (SAFE)

Completed Last updated 21 February 2023

What this trial tests

trial testing Screening, detection and referral for atrial fibrillation in Cardiovascular Diseases in 650 participants. Completed in 30 June 2022.

Timeline

3 September 2021

Primary endpoint
31 May 2022

30 June 2022

Quick facts

Lead sponsor	American Pharmacists Association Foundation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	650
Start date	3 September 2021
Primary completion	31 May 2022
Estimated completion	30 June 2022
Sites	1 location across United States

Drugs / interventions tested

Screening, detection and referral for atrial fibrillation

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

American Pharmacists Association Foundation

Who can join

18 and older, any sex, with Cardiovascular Diseases or Cardiac Arrhythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this demonstration project is to create an additional access point in the community at local pharmacies for atrial fibrillation screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Atrial fibrillation: epidemiology, screening and digital health.
Linz D, Gawalko M, Betz K, Hendriks JM, et al · · 2024 · cited 230× · PMID 38362546 · DOI 10.1016/j.lanepe.2023.100786
Solutions for Atrial Fibrillation Edvocacy (SAFE): Improving Awareness And Access To Afib Screening For Detection And Referral For Treatment.
Little J, Bonham AJ, Bluml BM. · · 2023 · PMID 38025178 · DOI 10.24926/iip.v14i2.5477

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other American Pharmacists Association Foundation trials

Trials by the same sponsor.

NCT04275934 — Blood Pressure First Medication Therapy Management · completed
NCT03372967 — Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05067114 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by American Pharmacists Association Foundation
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05067114.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing